Two versions of the fusion exist involving different exons of BCR and generating two different sized proteins: p210 BCR-ABL1 predominantly associated with chronic myeloid leukemia and p190 BCR-ABL1 linked to B cell precursor acute lymphoblastic leukemia (ALL). The gene discussed is ABL1; the disease is chronic myelogenous leukemia, BCR-ABL1 positive.